Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth in Children With H. Pylori-Associated Peptic Ulcer Disease
NCT07260006Recruiting
- Sponsor
- Can Tho University of Medicine and Pharmacy
- Start
- Oct 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bismuth subsalicylate in Helicobacter pylori infection and Peptic ulcer disease (PUD) (2 arms), sponsored by Can Tho University of Medicine and Pharmacy. Primary endpoint: Eradication rate of Helicobacter pylori infection. Started Oct 2024; status: recruiting.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT07260006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260006.